Prince T Cell Lymphoma 2010 Oncology Response Criteria

Preferred Label : Prince T Cell Lymphoma 2010 Oncology Response Criteria;

NCIt related terms : PRINCE TCELL LYMPHOMA 2010;

Alternative definition : CDISC: Phase III Placebo-Controlled Trial of Denileukin Diftitox for Patients with Cutaneous T-cell Lymphoma. (Prince HM, Duvic M, Martin A, Sterry W, Assaf C, Sun Y, Straus D, Acosta M, Negro-Vilar A. Phase III Placebo-Controlled Trial of Denileukin Diftitox for Patients with Cutaneous T-cell Lymphoma. J Clin Oncol. 2010 Apr 10;28(11):1870-7.);

NCI Metathesaurus CUI : CL504640;

Details

Origin ID

C126041;

UMLS CUI

C4288369;

Semantic type(s)
- Intellectual Product [UMLS semantic type]
concept_is_in_subset
- CDISC SDTM Category of Oncology Response Assessment Terminology [NCIt concept]
- CDISC SDTM Terminology [NCIt concept]
- Clinical Data Interchange Standards Consortium Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients